MedTrace Logo

Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer

NCT06385912 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1090

Last updated 2024-04-26

No results posted yet for this study

Summary

The study aims to investigate the prognostic and postoperative complication relevance of lymphadenectomy in advanced epithelial ovarian cancer patients who received neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS). The main question it aims to answer is:

Does systematic lymphadenectomy during interval debulking surgery have a significant impact on survival in patients with advanced epithelial ovarian cancer who have received neoadjuvant chemotherapy?

The progression-free survival (PFS), overall survival (OS), and postoperative complication were compared between the lymphadenectomy and no lymphadenectomy groups to answer the question.

Conditions

  • Ovarian Cancer
  • Postoperative Complications
  • Neoadjuvant Therapy
  • Lymph Node Excision

Interventions

PROCEDURE

lymphadenectomy

Systematic pelvic and para-aortic lymphadenectomy during IDS in lymphadenectomy group

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Qinglei Gao, MD, PhD · Tongji Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-01
Primary Completion
2021-02-10
Completion
2021-02-10

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06385912 on ClinicalTrials.gov